2-amino-5-methylthiazole,
2a5mt cpd,
2-Amino-5-methylthiazole,
7305-71-7,
5-methylthiazol-2-amine,
5-Methyl-1,3-thiazol-2-amine,
2-Thiazolamine, 5-methyl-,
2-Amino-5-methyl-thiazole,
5-METHYL-2-THIAZOLAMINE,
Thiazole, 2-amino-5-methyl-,
5-Methyl-2-aminothiazole,
UNII-7RAB78AF2P,
(5-Methylthiazol-2-yl)amine,
MELOXICAM RELATED COMPOUND B,
MFCD00078317,
NSC-523150,
7RAB78AF2P,
CHEMBL502447,
2-Amino-5-methylthiazole, 98%,
GUABFMPMKJGSBQ-UHFFFAOYSA-N,
5-methyl-1,3-thiazole-2-ylamine,
25T,
2-amino-5-methyl thiazole,
Meloxicam related compound B [USP],
Meloxicam specified impurity B [EP],
zlchem 346,
PubChem9924,
amino-5-methylthiazole,
Meloxicam related compound B RS [USP],
AC1Q2OGR,
5-methylthiazole-2-amine,
ACMC-1BFC3,
EC 423-800-5,
AC1L6Z0N,
5-methyl-thiazol-2-yl-amine,
KSC378G3D,
SCHEMBL160815,
CS-WAA0093,
SCHEMBL8086534,
CTK2H8331,
DTXSID10223329,
ZLC0188,
5-METHYL-THIAZOL-2-YLAMINE,
KS-00000A0G,
STR04839,
ZINC8652421,
5-Methyl-1,3-thiazol-2-amine #,
ANW-36281,
BBL012575,
BDBM50271509,
NSC523150,
SBB028194,
STK320523,
AKOS000120781,
AKOS005144921,
AB03001,
CS-W013636,
LS20937,
MCULE-8973432865,
RP19148,
RTR-030973,
TRA0043844,
AC-10741,
AJ-57848,
AK-26992,
BR-26992,
CJ-13318,
SC-06546,
TS-01581,
AB0007326,
AB1001274,
DB-020479,
ST2416431,
TL8005084,
TR-030973,
A1250,
AM20100697,
FT-0084769,
FT-0611180,
ST45255335,
Y9453,
EN300-21492,
A56079,
J-507967,
S09-0005,
F2190-0540,
Z1741960815,
Meloxicam impurity B, European Pharmacopoeia (EP) Reference Standard,
InChI=1/C4H6N2S/c1-3-2-6-4(5)7-3/h2H,1H3,(H2,5,6,
Meloxicam Related Compound B, United States Pharmacopeia (USP) Reference Standard,
null,
5-methyl-2-Thiophenamine,
2-Amio-5-Methyl Thiazole,
C4H6N2S,
CID351770,
CS-M-55628,
M-6185,
2-Amino-5-methylthiazole, 99% - 100G 100g,
2-AMINO-5 inverted exclamation mark feminineMETHYLTHIAZOLE,
55502-89-1,